{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:27:13Z","timestamp":1760297233695},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1996,12,1]],"date-time":"1996-12-01T00:00:00Z","timestamp":849398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1996,12]]},"DOI":"10.1007\/bf00180814","type":"journal-article","created":{"date-parts":[[2004,8,23]],"date-time":"2004-08-23T07:54:12Z","timestamp":1093247652000},"page":"379-386","source":"Crossref","is-referenced-by-count":10,"title":["Clinical and pharmacokinetic phase I trial of oral dimethylaminoetoposide (NK611) administered for 21 days every 35 days"],"prefix":"10.1007","volume":"14","author":[{"given":"I.","family":"Ra\u00dfmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schr\u00f6del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zucchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kaeser-Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rastetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. -R.","family":"Hanauske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00180814_CR1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/bmc.1130070207","volume":"7","author":"M Machida","year":"1993","unstructured":"Machida M, Tanaka S, Nakamori K: Simultaneous determination of NK611, a novel water-soluble derivative of etoposide, and its metabolite (DeNK611) in dogs plasma by column-switching high performance chromatography. Biomedic Chromatograph 7:82\u201385, 1993","journal-title":"Biomedic Chromatograph"},{"key":"BF00180814_CR2","unstructured":"Asta Medica GmbH. Investigator's drug brochure: NK611. Asta Medica GmbH 1993, p. 35"},{"key":"BF00180814_CR3","first-page":"436","volume":"33","author":"H Ekimoto","year":"1992","unstructured":"Ekimoto H, Okamoto K, Kusuma K, Mashiba H, Takeuchi T: Treatment schedule dependency of antitumor effects of NK611, a novel water-soluble analog of etoposide, on human xenografts. Proc Amer Assoc Cancer Res 33:436, 1992","journal-title":"Proc Amer Assoc Cancer Res"},{"key":"BF00180814_CR4","doi-asserted-by":"crossref","unstructured":"Pagani O, Zucchetti M, Sessa C, De Jong J, D'Incalci M, De Fusco M, Kaeser-Fr\u00f6hlich A, Hanauske A-R, Cavalli F: Phase I clinical and pharmacokinetic study of oral NK611, a new podophyllotoxin derivative. In press 1996","DOI":"10.1007\/s002800050524"},{"key":"BF00180814_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.annonc.a059180","volume":"6","author":"JD Hainsworth","year":"1995","unstructured":"Hainsworth JD, Greco FA: Etoposide: twenty years later. Ann Oncol 6:325\u2013341, 1995","journal-title":"Ann Oncol"},{"issue":"suppl. 1","key":"BF00180814_CR6","first-page":"98","volume":"3","author":"H Ekimoto","year":"1992","unstructured":"Ekimoto H, Okamoto K, Maruyma S, Mashiba S, Nakamori K, Takeuchi T: Preclinical characterization of NK611, a novel water-soluble etoposide analog. Ann Oncol 3(suppl. 1):98, 1992","journal-title":"Ann Oncol"},{"key":"BF00180814_CR7","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/0959-8049(95)00245-E","volume":"31A","author":"A-R Hanauske","year":"1995","unstructured":"Hanauske A-R, W\u00fcster KC, Lehmer A, Rotter M, Schneider P, Kaeser-Fr\u00f6hlich A, Rastetter J, Depenbrock H: Activity of NK611, a new epipodophyllotoxin derivative, against colony forming units from freshly explanted human tumors in vitro. Eur J Cancer 31A:1677\u20131681, 1995","journal-title":"Eur J Cancer"},{"key":"BF00180814_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0378-4347(93)E0453-W","volume":"654B","author":"M Zucchetti","year":"1994","unstructured":"Zucchetti M, De Fusco M, Sessa C, Fr\u00f6hlich A, Reichert S, D'Iticalci M: High-performance liquid chromatographic assay for determination of the novel podophyllotoxin derivative dimethylaminoetoposide (NK611) in human plasma. J Chromatogr 654B:97\u2013102, 1994","journal-title":"J Chromatogr"},{"key":"BF00180814_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0378-4347(94)00481-J","volume":"B 664","author":"M De Fusco","year":"1995","unstructured":"De Fusco M, D'Incalci M, Gentili B, Reichert S, Zucchetti M: High performance liquid chromatographic assay for the determination of the novel etoposide derivative dimethylaminoetoposide (NK611) and its metabolites in urine in cancer patients. J Chromatogr B 664:409\u2013412, 1995","journal-title":"J Chromatogr"},{"key":"BF00180814_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0010-468X(83)90006-5","volume":"16","author":"G Sacchi-Landriani","year":"1983","unstructured":"Sacchi-Landriani G, Guardabasso V, Rocchetti M: NI-Fit: a microcomputer program for non-linear fitting. Comput Programs Biomed 16:35\u201338, 1983","journal-title":"Comput Programs Biomed"},{"issue":"Suppl C","key":"BF00180814_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0305-7372(93)90046-T","volume":"19","author":"FA Greco","year":"1993","unstructured":"Greco FA: Chronic etoposide administration: overview of clinical experience. Canc Treat Rev 19(Suppl C):35\u201345, 1993","journal-title":"Canc Treat Rev"},{"issue":"Suppl 5","key":"BF00180814_CR12","first-page":"193","volume":"5","author":"T Schilling","year":"1994","unstructured":"Schilling T, Mross K, Berdel WE, Manegold C, Fiebig HH, Rastetter J, Hanauske A-R: Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611. Ann Oncol 5(Suppl 5):193, 1994","journal-title":"Ann Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00180814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00180814\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00180814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00180814.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T03:23:58Z","timestamp":1678505038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00180814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["BF00180814"],"URL":"https:\/\/doi.org\/10.1007\/bf00180814","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}